431 related articles for article (PubMed ID: 1675151)
21. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous homoharringtonine and interferon-alpha in the treatment of patients with chronic-phase chronic myelogenous leukemia.
O'Brien S; Talpaz M; Cortes J; Shan J; Giles FJ; Faderl S; Thomas D; Garcia-Manero G; Mallard S; Beth M; Koller C; Kornblau S; Andreeff M; Murgo A; Keating M; Kantarjian HM
Cancer; 2002 Apr; 94(7):2024-32. PubMed ID: 11932905
[TBL] [Abstract][Full Text] [Related]
23. Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia.
Seong CM; Giralt S; Kantarjian H; Xu J; Swantkowski J; Hayes K; Glassman AB; Khouri I; Korbling M; Thall P; Siciliano MJ; Champlin RE
J Clin Oncol; 2000 May; 18(9):1831-6. PubMed ID: 10784623
[TBL] [Abstract][Full Text] [Related]
24. Use of alpha-2a-interferon to treat cytogenetic relapse of chronic myeloid leukemia after marrow transplantation.
Higano CS; Chielens D; Raskind W; Bryant E; Flowers ME; Radich J; Clift R; Appelbaum F
Blood; 1997 Oct; 90(7):2549-54. PubMed ID: 9326220
[TBL] [Abstract][Full Text] [Related]
25. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
26. Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex.
Rowe JM; Rapoport AP; Ryan DH; Nilsson BI; Duerst RE; Packman CH; Abboud CN; DiPersio JF; Linder T; Wang N; Simonsson B; Liesveld JL
Bone Marrow Transplant; 1999 Nov; 24(10):1057-63. PubMed ID: 10578155
[TBL] [Abstract][Full Text] [Related]
27. Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia.
Carella AM; Lerma E; Corsetti MT; Dejana A; Basta P; Vassallo F; Abate M; Soracco M; Benvenuto F; Figari O; Podestá M; Piaggio G; Ferrara R; Sessarego M; Parodi C; Pizzuti M; Rubagotti A; Occhini D; Frassoni F
Blood; 1999 Mar; 93(5):1534-9. PubMed ID: 10029581
[TBL] [Abstract][Full Text] [Related]
28. Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.
Reece DE; Barnett MJ; Connors JM; Fairey RN; Fay JW; Greer JP; Herzig GP; Herzig RH; Klingemann HG; LeMaistre CF
J Clin Oncol; 1991 Oct; 9(10):1871-9. PubMed ID: 1919637
[TBL] [Abstract][Full Text] [Related]
29. Clonal expansion after bone marrow transplantation in a patient with chronic myelogenous leukemia.
Macera MJ; Botti AC; Verma RS; Coleman M; Thomas ED
Blut; 1988 Nov; 57(5):303-6. PubMed ID: 3058235
[TBL] [Abstract][Full Text] [Related]
30. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Elmaagacli AH; Beelen DW; Schaefer UW
Bone Marrow Transplant; 1997 Dec; 20(12):1045-55. PubMed ID: 9466277
[TBL] [Abstract][Full Text] [Related]
31. Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with philadelphia chromosome positive chronic myelogenous leukemia in early chronic phase.
Giles FJ; Kantarjian H; O'Brien S; Rios MB; Cortes J; Beran M; Koller C; Keating M; Talpaz M
Leuk Lymphoma; 2001 Apr; 41(3-4):309-19. PubMed ID: 11378543
[TBL] [Abstract][Full Text] [Related]
32. Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
Kantarjian HM; Talpaz M; Keating MJ; Estey EH; O'Brien S; Beran M; McCredie KB; Gutterman J; Freireich EJ
Cancer; 1991 Sep; 68(6):1201-7. PubMed ID: 1873771
[TBL] [Abstract][Full Text] [Related]
33. Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation.
Offit K; Burns JP; Cunningham I; Jhanwar SC; Black P; Kernan NA; O'Reilly RJ; Chaganti RS
Blood; 1990 Mar; 75(6):1346-55. PubMed ID: 2310831
[TBL] [Abstract][Full Text] [Related]
34. A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia.
Meloni G; Russo D; Baccarani M; Testoni N; Martinelli G; Fanin R; Zuffa E; Rosti G; Alimena G; Saglio G; Mandelli F; Tura S
Haematologica; 1999 Aug; 84(8):707-15. PubMed ID: 10457406
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabine.
Kantarjian HM; O'Brien S; Smith TL; Rios MB; Cortes J; Beran M; Koller C; Giles FJ; Andreeff M; Kornblau S; Giralt S; Keating MJ; Talpaz M
J Clin Oncol; 1999 Jan; 17(1):284-92. PubMed ID: 10458244
[TBL] [Abstract][Full Text] [Related]
36. Autologous transplantation with Philadelphia-negative progenitor cells for patients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferon.
McBride NC; Cavenagh JD; Newland AC; Lillington DM; Murrell C; Kelsey SM
Bone Marrow Transplant; 2000 Dec; 26(11):1165-72. PubMed ID: 11149726
[TBL] [Abstract][Full Text] [Related]
37. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
[TBL] [Abstract][Full Text] [Related]
38. Cytogenetic follow-up after bone marrow transplantation for Philadelphia-positive chronic myeloid leukemia.
Sessarego M; Frassoni F; Defferrari R; Bacigalupo A; Miceli S; Mareni C; Ajmar F
Cancer Genet Cytogenet; 1989 Oct; 42(2):253-61. PubMed ID: 2790760
[TBL] [Abstract][Full Text] [Related]
39. Autografting in chronic myeloid leukemia with cultured marrow: update of the Vancouver Study.
Barnett MJ; Eaves CJ; Phillips GL; Hogge DE; Klingemann HG; Lansdorp PM; Nantel SH; Reece DE; Shepherd JD; Sutherland HJ
Stem Cells; 1993 Oct; 11 Suppl 3():64-6. PubMed ID: 7905324
[TBL] [Abstract][Full Text] [Related]
40. Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583.
Ozer H; George SL; Schiffer CA; Rao K; Rao PN; Wurster-Hill DH; Arthur DD; Powell B; Gottlieb A; Peterson BA; Rai K; Testa JR; LeBeau M; Tantravahi R; Bloomfield CD
Blood; 1993 Nov; 82(10):2975-84. PubMed ID: 8219189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
